Advances in Molecular Diagnostics Technologies

Molecular Diagnostics have been around for more than fifty years, and every single decade has seen new leaps in technological advancements. Innovations in medical technologies usually take time to receive wide acceptance, but this has not stopped rapid evolution in the field of molecular diagnostics.

These advancements have helped overcome the many problems linked to test results’ viability and the challenges associated with clinical applicability. Some of these technological advances are billed to transform the face of infection and disease diagnostics for good and make treatment procedures a lot easier.

In this piece, we will cover some groundbreaking technologies that are changing the face of molecular diagnosis to include sample preparation, image analysis, microsatellite technology, and shotgun sequencing.

Five Molecular Diagnostics Technologies

The following are companies with innovative technologies for molecular diagnostics of a wide range of illnesses:

AperiomicsĀ 

Aperiomics is a cutting-edge company that uses shotgun metagenomic sequencing to analyze over 35,000 microorganisms, including viruses, bacteria, fungi, and parasites. They make updated test analysis at various points every year in order to discover newly-formed microbes. The company’s vision is to make as much information available to medical practitioners to proffer better-informed decisions concerning a patient.

Nanopec

Nanopec is another company specializing in automated molecular diagnostics system by introducing into the market a ceramic film that has the power to increase fluorescent signals considerably. This leaves no shadow of a doubt about the viability of a diagnosis as the chances of a patient getting a false result due to weak fluorescent signals are significantly reduced. The company is headquartered in Tucson, Arizona.

Promega

Promega is a company responsible for the production of MSI Analysis System, a molecular diagnostic tool used primarily for research purposes. Its main application is in the area of microsatellite instability (MSI) detection. Microsatellite instability is a type of instability in the gene which is connected to Lynch Syndrome cancer. Promega systems are used all over the world for clinical trials on over 15 tumor types.

Enzo

PCR-based AMPIPROBEĀ® system from Enzo is one of the fastest and low-cost ways of conducting assays. They make use of a very reliable PCR primer technology with strong fluorescent feedbacks, which, when implemented on newly-copied DNA, will bring about the destruction of fluorescence samples. This destruction of sample fluorescence is a high indicator of the number of RNA or DNA present in a specimen that is of particular interest.

Ceres Nanoscience

Ceres Nanosciences’s NanotrapĀ® is a trademarked product from Ceres, a medical technology production company. The product captures and analyzes particles concentrate on the main interest present in a sample. These include bacteria, pathogens, viruses, and nucleic acid. This unique approach culminates in top-quality results from the sample, which can then be used for future assays diagnostics.

Conclusion

It is clear that as the field of molecular diagnostics gets broader, we continue to see advancement in the kinds of medical technology that will be used in the early detection of hard to reach pathogens and highly microscopic viruses. The possibilities in this field are simply endless.